How to buy Intersect ENT stock

Intersect ENT, Inc is a medical devices business based in the US. Intersect ENT shares (XENT) are listed on the NASDAQ and all prices are listed in US Dollars. Intersect ENT employs 402 staff and has a trailing 12-month revenue of around USD$84.1 million.

How to buy shares in Intersect ENT

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Intersect ENT. Find the stock by name or ticker symbol: XENT. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Intersect ENT reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Intersect ENT, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Intersect ENT. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. XENT shares summary
2. Compare share dealing platforms
3. Is XENT stock a buy or sell?
4. Stock performance over time
5. Can I short XENT shares?
6. Intersect ENT's financials
7. How volatile are XENT shares?
8. Does Intersect ENT pay a dividend?
9. Have XENT shares ever split?
10. Other common questions

Intersect ENT share price

Use our graph to track the performance of XENT stocks over time.

Intersect ENT shares at a glance

• Key figures

Information last updated 2021-02-24.

52-week range	USD$5.97 - USD$26.98
50-day moving average	USD$24.192
200-day moving average	USD$20.2021
Wall St. target price	USD$23
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.129

Buy Intersect ENT shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Intersect ENT stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Intersect ENT, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Intersect ENT shares

There are currently 965,560 Intersect ENT shares held short by investors – that's known as Intersect ENT's "short interest". This figure is 12.7% down from 1.1 million last month.

There are a few different ways that this level of interest in shorting Intersect ENT shares can be evaluated.

Intersect ENT's "short interest ratio" (SIR)

Intersect ENT's "short interest ratio" (SIR) is the quantity of Intersect ENT shares currently shorted divided by the average quantity of Intersect ENT shares traded daily (recently around 232105.76923077). Intersect ENT's SIR currently stands at 4.16. In other words for every 100,000 Intersect ENT shares traded daily on the market, roughly 4160 shares are currently held short.

However Intersect ENT's short interest can also be evaluated against the total number of Intersect ENT shares, or, against the total number of tradable Intersect ENT shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Intersect ENT's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Intersect ENT shares in existence, roughly 30 shares are currently held short) or 0.0298% of the tradable shares (for every 100,000 tradable Intersect ENT shares, roughly 30 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Intersect ENT.

Find out more about how you can short Intersect ENT stock.

Have Intersect ENT's shares ever split?

Intersect ENT's shares were split on a 1:4 basis on 11 July 2014. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Intersect ENT shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Intersect ENT shares which in turn could have impacted Intersect ENT's share price.

Intersect ENT share price volatility

Over the last 12 months, Intersect ENT's shares have ranged in value from as little as $5.97 up to $26.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intersect ENT's is 1.6286. This would suggest that Intersect ENT's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Intersect ENT overview

Intersect ENT, Inc., a drug delivery company, researches and develops products for the treatment of patients with ear, nose, and throat conditions in the United States. The company offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for refractory disease for the treatment of patients in the physician office setting. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.

Frequently asked questions

• What percentage of Intersect ENT is owned by insiders or institutions?

  Currently 2.857% of Intersect ENT shares are held by insiders and 89.689% by institutions.

• How many people work for Intersect ENT?

  Latest data suggests 402 work at Intersect ENT.

• When does the fiscal year end for Intersect ENT?

  Intersect ENT's fiscal year ends in December.

• Where is Intersect ENT based?

  Intersect ENT's address is: 1555 Adams Drive, Menlo Park, CA, United States, 94025

• What is Intersect ENT's ISIN number?

  Intersect ENT's international securities identification number is: US46071F1030

• What is Intersect ENT's CUSIP number?

  Intersect ENT's Committee on Uniform Securities Identification Procedures number is: 46071F103